iBio, Inc.
iBio is a developer of next-generation biopharmaceuticals and a pioneer in sustainable, plant-based biologics manufacturing. Its FastPharming System® combines vertical farming, automated hydroponics, and novel glycosylation technologies to rapidly deliver high-quality recombinant proteins. iBio is developing proprietary therapeutics and vaccines for the treatment of cancers and other diseases while providing CDMO services to its clients, all supported by iBio’s advanced bioanalytical capabilities and Glycaneering(SM) technology.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No